EXCELLYSE I

EXCELLYSE I
Regulatory status
CE IVD
Reactivity
Human
Application
FC (QC tested)
Variant
100 ml
ED7065
In stock
Variant
0.1 mg
11-261-C100
In stock
Product details
References
Application
FC (QC tested)
Reactivity
Human
Description
The EXCELLYSE I lysing solution is intended for red blood cell lysis following antibody staining of human peripheral blood leukocytes. The lysing solution is appropriate for use with EXBIO single colour monoclonal antibodies and KOMBITEST reagents and may be used in both lyse/wash and lyse/no wash protocol.
Contents
EXCELLYSE I lysing solution is a ready to use reagent provided as 100 ml package of proprietary buffered solution containing < 5 % formaldehyde. This quantity is sufficient for 500-1000 tests.
Storage and handling
Store the product at 2-25°C. Expiration is stated on the label.
Exbio licence note
Unless indicated otherwise, all products are For Research Use Only and not for diagnostic use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s. © 2019 EXBIO Praha, a.s. All rights reserved.

General references:

PH Carter, S Resto-Ruiz, GC Washington, S Ethridge, A Palini, R Vogt, M Waxdal, T Fleisher, PD Noguchi, GE Marti: Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations, Cytometry 13:68-74 (1992). Wiley-Liss, Inc. 1992.
PubMed
KR Tamul, JL Schmitz, K Kane, and JD Folds: Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies, Clin. Diagn. Lab. Immunol. 1995 May; 2(3): 337–342.
PubMed
Variant
100 ml
ED7065
In stock
Variant
0.1 mg
11-261-C100
In stock